论文部分内容阅读
鼻咽癌是我国一种常见的恶性程度高、发展快、转移早的癌瘤。肿瘤部位的隐蔽或取活检组织技术的差异,使鼻咽癌患者往往难以得到早期的病理组织学确诊。EBV-VCA-IgA的检测已被公认是鼻咽癌早期发现、早期诊断、预后监测及大规模普查的敏感、可靠、简便的方法[1]。我们自1985年开展免疫酶法EBV-VCA-IgA捡测至今,共检测了1982份血清标本。通过实践我们体会到,EBV-VCA-IgA的捡测若能很好的与病理组织学检查结合起来,将是提高鼻咽癌早期确诊率的有效途径。
Nasopharyngeal carcinoma is a common malignant tumor in China with rapid development and early metastasis. Hidden tumor or take the biopsy tissue technology differences, so that patients with nasopharyngeal carcinoma are often difficult to get early pathological diagnosis. The detection of EBV-VCA-IgA has been recognized as a sensitive, reliable and simple method for the early detection, early diagnosis, prognosis monitoring and large-scale census of nasopharyngeal carcinoma [1]. Since 1985, we have carried out immunoenzymatic EBV-VCA-IgA test to date, a total of 1982 serum samples were detected. Through practice, we realize that EBV-VCA-IgA if the combination of good detection and histopathological examination will be an effective way to improve the early diagnosis of nasopharyngeal carcinoma.